Skip to main content
TipRanks
Go Ultimate75% OFF

AgomAb Therapeutics NV ADR (AGMB) Cash flow

41 Followers

AgomAb Therapeutics NV ADR Cash Flow

AGMB's free cash flow for Q4 2025 was €-13.18M. For the 2025 fiscal year, AGMB's free cash flow was decreased by €-4.00K and operating cash flow was €-13.17M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowMar 26
€ -51.74M
€ -33.00M
€ -338.00K
€ 86.42M
€ -51.74M

Currency in EUR

AgomAb Therapeutics NV ADR Cash Flow

-60M-50M-40M-30M-20M-10M02025OperatingInvestingFinancing